Literature DB >> 22503122

Occult tumors presenting with negative imaging: analysis of the literature.

Prashant Chittiboina1, David E Connor, Gloria Caldito, Joseph W Quillin, Jon D Wilson, Anil Nanda.   

Abstract

OBJECT: Some patients presenting with neurological symptoms and normal findings on imaging studies may harbor occult brain tumors that are undetectable on initial imaging. The purpose of this study was to analyze the cases of occult brain tumors reported in the literature and to determine their modes of presentation and time to diagnosis on imaging studies.
METHODS: A review of the literature was performed using PubMed. The authors found 15 articles reporting on a total of 60 patients with occult tumors (including the authors' illustrative case).
RESULTS: Seizures were the mode of initial presentation in a majority (61.7%) of patients. The initial imaging was CT scanning in 55% and MRI in 45%. The mean time to diagnosis for occult brain tumors was 10.3 months (median 4 months). The time to diagnosis (mean 7.5 months, median 3.2 months) was shorter (p = 0.046) among patients with seizures. Glioblastoma multiforme (GBM) was found more frequently among patients with seizures (67.6% vs 34.8%, p = 0.013). The average time to diagnosis of GBM was shorter than the time to diagnosis of other tumors; the median time to diagnosis was 3.2 months for GBM and 6 months for other tumors (p = 0.04). There was no predilection for side or location of occult tumors. In adult patients, seizures may be predictive of left-sided tumors (p = 0.04).
CONCLUSIONS: Based on the results of this study, the authors found that in patients with occult brain tumors, the time to diagnosis is shorter among patients with seizures and also among those with GBM.

Entities:  

Mesh:

Year:  2012        PMID: 22503122     DOI: 10.3171/2012.3.JNS112098

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Radiologically occult medulloblastoma with hydrocephalus: case report.

Authors:  Hirokuni Honma; Hideki Ogiwara
Journal:  Childs Nerv Syst       Date:  2017-05-29       Impact factor: 1.475

2.  Extracellular Vesicle Mediated Vascular Pathology in Glioblastoma.

Authors:  Cristiana Spinelli; Nadim Tawil; Lata Adnani; Janusz Rak; Dongsic Choi
Journal:  Subcell Biochem       Date:  2021

3.  Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations.

Authors:  Nathalie Magnus; Delphine Garnier; Brian Meehan; Serge McGraw; Tae Hoon Lee; Maxime Caron; Guillaume Bourque; Chloe Milsom; Nada Jabado; Jacquetta Trasler; Rafal Pawlinski; Nigel Mackman; Janusz Rak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

Review 4.  Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.

Authors:  Fred H Hochberg; Nadia A Atai; David Gonda; Michael S Hughes; Brolin Mawejje; Leonora Balaj; Robert S Carter
Journal:  Expert Rev Mol Diagn       Date:  2014-05       Impact factor: 5.225

Review 5.  ExRNA in Biofluids as Biomarkers for Brain Tumors.

Authors:  Robert C Rennert; Fred H Hochberg; Bob S Carter
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

Review 6.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

7.  Visual field changes as an early indicator of glioblastoma multiforme progression: two cases of functional vision changes before MRI detection.

Authors:  Kate Xie; Catherine Y Liu; Anton N Hasso; Robert Wade Crow
Journal:  Clin Ophthalmol       Date:  2015-06-11

8.  Brain neoplasms and coagulation-lessons from heterogeneity.

Authors:  Esterina D'Asti; Yi Fang; Janusz Rak
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

9.  Glioblastoma Shortly after a Normal Conventional Brain Magnetic Resonance Imaging: A Report of Two Cases and Review of the Literature.

Authors:  Tayfun Hakan; Erhan Çelikoglu
Journal:  Asian J Neurosurg       Date:  2021-05-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.